Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024 | 09/14 03:00 | businesswire.com |
Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone | 09/06 13:37 | benzinga.com |
Bicycle Therapeutics Is Looking Increasingly Attractive | 08/20 07:37 | seekingalpha.com |
What Makes Bicycle Therapeutics (BCYC) a New Buy Stock | 08/09 13:01 | zacks.com |
Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High? | 08/09 10:55 | zacks.com |
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 08/01 16:05 | businesswire.com |
Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024 | 07/22 07:00 | businesswire.com |
Are Medical Stocks Lagging Bicycle Therapeutics (BCYC) This Year? | 06/27 10:40 | zacks.com |
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio | 06/21 09:25 | zacks.com |
Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year? | 06/11 10:40 | zacks.com |